| Title | Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma. |
| Publication Type | Journal Article |
| Year of Publication | 2022 |
| Authors | Holstein, SA, Asimakopoulos, F, Azab, AKareem, Bianchi, G, Bhutani, M, Crews, LA, Cupedo, T, Giles, H, Gooding, S, Hillengass, J, John, L, Kaiser, S, Lee, L, Maclachlan, K, Pasquini, MC, Pichiorri, F, Shah, N, Shokeen, M, Shy, BR, Smith, EL, Verona, R, Usmani, SZ, McCarthy, PL |
| Journal | Transplant Cell Ther |
| Volume | 28 |
| Issue | 8 |
| Pagination | 446-454 |
| Date Published | 05/2022 |
| ISSN | 2666-6367 |
| Keywords | Bone Marrow, Cell- and Tissue-Based Therapy, Clinical Trials as Topic, Humans, Multiple Myeloma |
| Abstract | The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on January 7, 2022. This workshop included presentations by basic, translational, and clinical researchers with expertise in plasma cell dyscrasias. Four main topics were discussed: platforms for myeloma disease evaluation, insights into pathophysiology, therapeutic target and resistance mechanisms, and cellular therapy for multiple myeloma. Here we provide a comprehensive summary of these workshop presentations. |
| DOI | 10.1016/j.jtct.2022.05.019 |
| Alternate Journal | Transplant Cell Ther |
| PubMed ID | 35605882 |
| PubMed Central ID | PMC9357156 |
| Grant List | U10 HL069294 / HL / NHLBI NIH HHS / United States U24 HL138660 / HL / NHLBI NIH HHS / United States R01 CA248493 / CA / NCI NIH HHS / United States K08 CA245100 / CA / NCI NIH HHS / United States R37 CA252040 / CA / NCI NIH HHS / United States R01 CA252937 / CA / NCI NIH HHS / United States |
